Matte Kasi Viswanadh

4PUBLICATIONS
14CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 30, 2026
3-Nitropropionic Acid-Induced Huntington's Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model Gaps, and Future Directions.

|Aug 27, 2021
Harnessing immunological targets for COVID-19 immunotherapy.

Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya

|Sep 18, 2020
Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy.

Matte Kasi Viswanadh, Vikas, Abhishek Jha

|Sep 02, 2020
Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer.

Narendra, Abhishesh Kumar Mehata, Matte Kasi Viswanadh

Pageof 1

Frequent Collaborators

3 joint publications

Madaswamy S Muthu

2 joint publications

Abhishesh Kumar Mehata

1 joint publications

Abhishek Jha

1 joint publications

Suruchi Poddar